Literature DB >> 21971537

Clinical factors associated with non-polypoid colonic adenomas ≥6 mm: a prospective study in an asymptomatic population using a high-definition colonoscope.

Maria E Johnson1, Richard Feinn, Joseph C Anderson.   

Abstract

OBJECTIVES: To examine the clinical factors associated with adenomas ≥6 mm presenting as non-polypoid polyps.
METHODS: We conducted a prospective cross-sectional examination with a target population of consecutive asymptomatic patients presenting to a University endoscopy center for screening colonoscopy. Data, which included demographics, known colorectal cancer risk factors, and medications, were collected. One endoscopist using a high-definition wide-angle colonoscope performed all of the colonoscopies. Polyp morphology was classified according to the JRSC (Japanese Research Society for Cancer of Colon and Rectum) JRSC guidelines.
RESULTS: A total of 600 patients were screened and 150 adenomas ≥6 mm were detected. Of these 150 adenomas, 70 adenomas had a non-polypoid morphology while 80 were polypoid. Adenomas were more likely to present as non-polypoid in women as compared with men (adjusted odds ratio (AOR)=2.49; 95% confidence interval (CI)=1.08-5.75, P=0.03). Location of the adenoma in the proximal colon (AOR=4.21; 95% CI=1.83-9.71, P=0.001) and smoking (AOR=2.54; 95% CI=1.01-6.38, P=0.048) were independent predictors of flat morphology. In addition, advanced adenomas were also more likely to be flat in women (AOR=7.99; 95% CI=1.32-48.39, P=0.02) and proximal location was an independent predictor of flat morphology.
CONCLUSIONS: Adenomas ≥6 mm and advanced lesions were more likely to present as non-polypoid polyps in women when compared with men. Proximal location and smoking were also observed to be independent predictors of flat morphology.

Entities:  

Mesh:

Year:  2011        PMID: 21971537     DOI: 10.1038/ajg.2011.254

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

Review 1.  Do recent epidemiologic observations impact who and how we should screen for CRC?

Authors:  Ethan Bortniker; Joseph C Anderson
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

2.  Same-day 2-L PEG-citrate-simethicone plus bisacodyl vs split 4-L PEG: Bowel cleansing for late-morning colonoscopy.

Authors:  Annalisa de Leone; Darina Tamayo; Giancarla Fiori; Davide Ravizza; Cristina Trovato; Giuseppe De Roberto; Linda Fazzini; Marco Dal Fante; Cristiano Crosta
Journal:  World J Gastrointest Endosc       Date:  2013-09-16

3.  Antibiotic exposure and the development of coeliac disease: a nationwide case-control study.

Authors:  Karl Mårild; Weimin Ye; Benjamin Lebwohl; Peter H R Green; Martin J Blaser; Tim Card; Jonas F Ludvigsson
Journal:  BMC Gastroenterol       Date:  2013-07-08       Impact factor: 3.067

4.  Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case-Control Study.

Authors:  Su Young Kim; Hyun-Soo Kim; Yun Tae Kim; Jung Kuk Lee; Hong Jun Park; Hee Man Kim; Dae Ryoung Kang
Journal:  Clin Transl Gastroenterol       Date:  2021-04-30       Impact factor: 4.396

5.  Prognostic Significance of DR-70 Levels in Dysplastic Colorectal Polyps.

Authors:  Atakan Yesil; Gul Babacan Abanonu; Yasar Colak; Nurcan Paker; Can Gonen
Journal:  Gastroenterol Res Pract       Date:  2013-11-21       Impact factor: 2.260

6.  Incidence and distribution of advanced colorectal adenomas in patients undergoing colonoscopy for screening, surveillance, and symptoms.

Authors:  Haifeng Kang; Yanmei Yang; Jianwei Qiu; Junbo Qian; Xiaobo Li
Journal:  Cancer Manag Res       Date:  2018-09-25       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.